ANIMAL ARTIFICIAL REPRODUCTION BIOTECHNOLOGIES
“ IMV Technologies represents half a century of history in biotechnologies dedicated to assisted reproduction. The management team is pleased with its partnership with Qualium Investissement, which enables the Group to accelerate its strategy of product innovations and its international development in high growth markets such as Asia and Latin America "
Gilles de Robert
Gilles de ROBERT
Chief Executive Officer
IMV Technologies designs, manufactures and sells equipment and consumables used in the collection, packaging, cryopreservation, monitoring and insemination of animal semen from over 14 species. IMV Technologies has a respective 65% and 25% share of the global market for cattle and swine species, which represent its two main lines of business.
With six foreign subsidiaries (US, India, China, Italy, the Netherlands and Great-Britain), and a vast network of distributors across more than 120 countries, IMV Technologies generates more than 80% of its revenue internationally.
The group has five production sites, the largest of which is in L'Aigle.
Partner in charge
Investment date: 2014